XILIO THERAPEUTICS INC (XLO:NASDAQ)
$8.89 0.38 (4.4653%)
Analysed XILIO THERAPEUTICS INC (XLO:NASDAQ) News Sources
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03-04-2026
yahoo.com
Xilio Therapeutics (XLO) Upgraded to Buy: What Does It Mean for the Stock?
01-04-2026
yahoo.com
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
26-03-2026
yahoo.com
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
23-03-2026
yahoo.com
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
17-03-2026
yahoo.com
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
12-03-2026
yahoo.com
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
02-03-2026
yahoo.com
Xilio Therapeutics Announces Pricing of Underwritten Offering
12-02-2026
yahoo.com
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
08-01-2026
yahoo.com
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2025 Financial Results
13-11-2025
yahoo.com
What is the current price of XILIO THERAPEUTICS INC (XLO:NASDAQ)?
The current price of XILIO THERAPEUTICS INC (XLO:NASDAQ) is $8.89.
XILIO THERAPEUTICS INC (XLO:NASDAQ) absolute price change since previous trading day?
The absolute price change of XILIO THERAPEUTICS INC (XLO:NASDAQ) since the previous trading day is $0.38.
XILIO THERAPEUTICS INC (XLO:NASDAQ) percentage price change since previous trading day?
The percentage price change of XILIO THERAPEUTICS INC (XLO:NASDAQ) since the previous trading day is 4.4653%.
What is the most recent average sentiment score for XILIO THERAPEUTICS INC (XLO:NASDAQ)?
The most recent average sentiment score for XILIO THERAPEUTICS INC (XLO:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for XILIO THERAPEUTICS INC (XLO:NASDAQ)?
The most recent sentiment for XILIO THERAPEUTICS INC (XLO:NASDAQ) is .
SEC-8K** Filing Available For XILIO THERAPEUTICS INC (XLO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.